|
Contact
information:
Telephone: (514) 345-4735 or
345-4931, ext. 6209
e-mail: cheri.l.deal@umontreal.ca
website:
http://www.recherche-sainte-justine.qc.ca/en/chercheurs/8
Projects for Thesis
Supervision:
1. Genetic and epigenetic regulation of IGFBP3.
2. Parental origin of the X-chromosome in
Turner Syndrome and its impact on phenotype.
3. GH-IGF axis in Small for gestational age
infants.
Recent
Publications:
Khatchadourian, K., Huot, C., Alos, N., Van
Vliet, G. and Deal, C.
(2008)
Impact of patient characteristics and clinical factors on decision to
initiate growth hormone treatment in Turner Syndrome. Hormone Research,
In Press.
Bessette, B., Paquette, J., Ledru, E. and
Deal, C. (2007)
Identification of a functional insulin response element in the human
IGFBP3 promoter and potential implication of adjacent single nucleotide
polymorphisms. Endocrinology 148: 6007-6018.
Hamelin, C., Anglin, G., Quigley, C. and
Deal, C. (2006)
Imprinting effects on growth hormone responsiveness and on neurosensory
hearing loss in Turner Syndrome. J. Clin. Endocrinol. Metab. 91:
3002-3010.
|
